Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Valerio Therapeutics